Sara R Martins-Neves

IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.

A. Cleton-Jansen, C. Fontes-Ribeiro, C. Gomes, 2018, Cancer letters.

Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line

A. Paiva, Sara R Martins-Neves, Célia M Gomes, 2012, BMC Cancer.

Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.

C. Fontes-Ribeiro, C. Gomes, Sara R Martins-Neves, 2015, Life sciences.

Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters

C. Gomes, Sara R Martins-Neves, Sara R. Martins-Neves, 2022, International journal of molecular sciences.

Osteosarcoma Stem Cells Have Active Wnt/β‐catenin and Overexpress SOX2 and KLF4

Anne-Marie Cleton-Jansen, A. Cleton-Jansen, C. Gomes, 2016, Journal of cellular physiology.

Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells

C. Fontes-Ribeiro, C. Gomes, Sara R Martins-Neves, 2017, Cancer Chemotherapy and Pharmacology.

Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling.

A. Cleton-Jansen, C. Fontes-Ribeiro, C. Gomes, 2016, Cancer letters.

Therapy‐induced enrichment of cancer stem‐like cells in solid human tumors: Where do we stand?

A. Cleton-Jansen, Sara R Martins-Neves, C. Gomes, 2018, Pharmacological research.